HOME >> MEDICINE >> NEWS
Novel antibiotic provides rapid relief from symptoms of tonsillitis/pharyngitis, study shows

Ketek (telithromycin), a novel compound from a new family of antibiotics, administered once daily for five days to patients suffering from tonsillitis/pharyngitis, provided equivalent clinical and bacteriological outcomes as those observed in patients receiving a 10-day course of treatment with penicillin V, a new study shows.

The more rapid symptom relief achieved with Ketek, the first antibiotic from the ketolide family to be developed for clinical use, may suggest a potential for a faster return to usual activities, and fewer days lost from work or school, for people with tonsillitis/pharyngitis resulting from group A b-haemoliytic streptococcus (GABHS) bacteria. GABHS is the most common bacterial cause of tonsillitis/pharyngitis.

The study results, reported today at the 11th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting in Istanbul, Turkey, were among several scientific presentations involving Ketek.

"This is an important study as it demonstrates the clinical and bacteriological effectiveness and symptom relief of Ketek in treating what is a very common upper respiratory tract infection," said Dr. Joanne Chang, Aventis Pharma.

The double-blinded study enrolled 396 patients between the ages of 15 and 65 with clinical signs and symptoms of acute tonsillopharyngitis, and who either had a positive streptococcal A antigen test or a positive throat culture for GABHS. These patients were randomized (198 patients to each group) to receive either 800 mg once daily Ketek followed by placebo for five days, or penicillin V 500 mg three-times daily for 10 days. Clinical and bacteriological outcomes were assessed at post-therapy (days 16-21) and late post-therapy (days 38-45).

At the post-therapy visit, bacteriological outcome was satisfactory in 79.7 percent and 79.3 percent of patients, and clinical cure was achieved in 85.9 percent and 85.8 percent of patients in the Ketek (198 patients) and penicillin V (197
'"/>

Contact: Liz Rickard
elizabeth.rickard@ketchum.com
44-0-20-7611-3633
Ketchum
4-Apr-2001


Page: 1 2

Related medicine news :

1. Novel therapy tested in mice could chase away cat allergies
2. Novel antibiotic shows promise in shortening treatment duration of tuberculosis
3. Novel p53 gene-based therapy boosts immune system and reduces tumor size
4. Novel drugs help solve Gleevec resistance
5. Novel imaging technique shows abnormal brain anatomy in children with ADHD
6. Novel drug-antidote strategy provides greater control of drug action
7. Novel imaging technique shows lymph nodes, metastases in breast cancer without surgery
8. Novel delivery method for nutrients wins Kaye Innovation Award for Hebrew university students
9. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
10. Novel findings about neovessel formation
11. Novel MRI technique provides clear images of blood flow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2017)... , ... February 21, 2017 , ... Along with Valentine’s ... lifestyle and make small changes that can lead to a lifetime of heart health. ... of a cardiac emergency. , The Athletic Trainers’ Society of New Jersey ...
(Date:2/20/2017)... ... February 20, 2017 , ... MRI screening improves early ... new study from Germany published online in the journal Radiology . , ... better sensitivity than mammography and ultrasound. Currently, guidelines reserve breast MRI screening for women ...
(Date:2/20/2017)... ... February 20, 2017 , ... Daily Body Restore, "DBR" ... levels of “good” bacteria in the body, announced its Daily Body Restore® supplement ... , Daily Body Restore® is made with a unique combination of digestive enzymes ...
(Date:2/20/2017)... Jacksonville, Fla. (PRWEB) , ... February 20, 2017 , ... ... Anderson Cancer Center in Houston, Dr. Christopher Pezzi remembers the excitement of the surgeon ... you believe they pay us to do this? Don’t tell anyone, but I would ...
(Date:2/20/2017)... ... , ... Researchers at the University of Pittsburgh School of Medicine have uncovered ... predict response to a particular class of drugs, not just in patients with thyroid ... findings were published in Proceedings of the National Academy of Science. , “These results ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... 2017   Spectrum Pharmacy Products , a division ... exhibiting at the Educational Conference, February 22-25, 2017, in ... Coronado Bay Resort. Spectrum will be showcasing its new ... . The annual Educational Conference is presented by the ... Compounding Pharmacists (IACP) and the American College of Veterinary ...
(Date:2/20/2017)... -- This report analyzes the worldwide markets for Peripheral Arterial Disease (PAD) ... for the US, Canada , ... Asia-Pacific , Latin America , and ... http://www.reportlinker.com/p04707127-summary/view-report.html Annual estimates and forecasts are ... historic analysis is provided for these markets. Market data and ...
(Date:2/20/2017)... --  Orion Health ™ announced today the ... to the Amazon Web Services, Inc. (AWS) Cloud. ... records globally. "We are impressed by Orion ... on modern, scalable technology," said Steve Halliwell , ... Cloud gives healthcare companies a powerful tool to enable ...
Breaking Medicine Technology:
Cached News: